The role of the AR/ER ratio in ER-positive breast cancer patients

The significance of androgen receptor (AR) in breast cancer (BC) management is not fully defined, and it is still ambiguous how the level of AR expression influences oestrogen receptor-positive (ER+) tumours. The aim of the present study was to analyse the prognostic impact of AR/ER ratio, evaluated...

Full description

Autores:

Tipo de recurso:

Fecha de publicación:

2018

Institución:

Universidad del Rosario

Repositorio:

Repositorio EdocUR - U. Rosario

Idioma:

eng

OAI Identifier:

oai:repository.urosario.edu.co:10336/23923

Acceso en línea:

https://doi.org/10.1530/ERC-17-0417
https://repository.urosario.edu.co/handle/10336/23923

Palabra clave:

Androgen receptor
Epidermal growth factor receptor 2
Estrogen receptor
Ki 67 antigen
Progesterone receptor
Tumor marker
Androgen receptor
Estrogen receptor
Adult
Aged
Article
Cancer grading
Cancer patient
Cancer prognosis
Cancer recurrence
Cancer survival
Cohort analysis
Controlled study
Disease free interval
Disease specific survival
Estrogen receptor positive breast cancer
Female
Histopathology
Human
Human tissue
Immunohistochemistry
Luminal a breast cancer
Luminal b breast cancer
Lymph node metastasis
Major clinical study
Mastectomy
Partial mastectomy
Recurrence risk
Retrospective study
Survival rate
Tumor volume
Breast tumor
Metabolism
Middle aged
Pathology
Prognosis
Very elderly
Adult
Aged
Aged, 80 and over
Breast neoplasms
Female
Humans
Middle aged
Prognosis
Androgen receptor
Breast cancer
Oestrogen receptor
Prosigna
Subtypes
androgen
human
estrogen
Ar protein
Receptors
Receptors

Rights

License

Abierto (Texto Completo)